Simultaneous immunization against tuberculosis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Tchilian, Elma Z ^a   Ronan, Edward O ^a   de Lara, Catherine ^a   Lee, Lian Ni ^a   Franken, Kees L M C ^b   Vordermeier, Martin H ^c   Ottenhoff, Tom H M ^b   Beverley, Peter C L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHOLERA TOXIN; CYTOKINE; EARLY SECRETORY ANTIGENIC TARGET 6; MYCOBACTERIUM ANTIGEN; PHOSPHORYL LIPID A; PROTEIN RV1284; RECOMBINANT ANTIGEN TB10.4; RECOMBINANT MYCOBACTERIUM ANTIGEN 85A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL LOAD; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GROWTH INHIBITION; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SIMULTANEOUS BCG VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; DRUG ADMINISTRATION ROUTES; FEMALE; IMMUNIZATION; LUNG; MICE; MICE, INBRED C57BL; TIME FACTORS; TUBERCULOSIS; VACCINES, SUBUNIT;

ANIMALIA; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 81155131557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027477     Document Type: Article

References (35)

1. Kaufmann SH, (2010) Future vaccination strategies against tuberculosis: Thinking outside the box. Immunity 33: 567-577.
2. Ronan EO, Lee LN, Beverley PC, Tchilian EZ, (2009) Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection. PLoS One 4: e8235.
3. Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, et al. (2005) Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinb) 85: 29-38.
4. Tchilian EZ, Desel C, Forbes EK, Bandermann S, Sander CR, et al. (2009) Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis. Infect Immun 77: 622-631.
5. Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, et al. (2008) Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 181: 4955-4964.
6. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, Macaulay M, Rhodes SG, et al. (2009) Viral booster vaccines improve BCG-induced protection against bovine Tuberculosis. Infect Immun 77: 3364-3373.
7. Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, et al. (2009) MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One 4: e5264.
8. Sharpe SA, McShane H, Dennis MJ, Basaraba RJ, Gleeson F, et al. (2010) Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin Vaccine Immunol 17: 1170-1182.
9. Skeiky YA, Dietrich J, Lasco TM, Stagliano K, Dheenadhayalan V, et al. (2010) Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen. Vaccine 28: 1084-1093.
10. Reed SG, Coler RN, Dalemans W, Tan EV, DeLa Cruz EC, et al. (2009) Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci U S A 106: 2301-2306.
11. Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, et al. (2011) A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Medicine 17: 189-194.
12. Dietrich J, Billeskov R, Doherty TM, Andersen P, (2007) Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. J Immunol 178: 3721-3730.
13. Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, et al. (2003) Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 171: 1602-1609.
14. Santosuosso M, McCormick S, Zhang X, Zganiacz A, Xing Z, (2006) Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect Immun 74: 4634-4643.
15. Dietrich J, Andersen C, Rappuoli R, Doherty TM, Jensen CG, et al. (2006) Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 177: 6353-6360.
16. Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, et al. (2007) Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 75: 4105-4115.
17. Garcia-Contreras L, Wong YL, Muttil P, Padilla D, Sadoff J, et al. (2008) Immunization by a bacterial aerosol. Proc Natl Acad Sci U S A 105: 4656-4660.
18. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, et al. (2008) ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A 105: 10961-10966.
19. Cooper AM, (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27: 393-422.
20. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
21. Mollenkopf HJ, Kursar M, Kaufmann SH, (2004) Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Mycobacterium bovis bacille Calmette-Guerin induce equal protection. J Infect Dis 190: 588-597.
22. Jeyanathan M, Mu J, McCormick S, Damjanovic D, Small CL, et al. (2010) Murine Airway Luminal Anti-tuberculosis Memory CD8 T Cells by Mucosal Immunization are Maintained Via Antigen-driven in situ Proliferation, Independent of Peripheral T Cell Recruitment. Am J Respir Crit Care Med 181: 862-872.
23. Franken KL, Hiemstra HS, van Meijgaarden KE, Subronto Y, den Hartigh J, et al. (2000) Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 18: 95-99.
24. Rustad TR, Harrell MI, Liao R, S DR, (2008) The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One 3: e1502.
25. Cortes EA, Kaveh D, Nunez-Garcia J, Hogarth PJ, Vordermeier HM, (2010) Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice. PLoS One 5: e11319.
26. Urdahl KB, Shafiani S, Ernst JD, (2011) Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immun 4: 288-293.
27. Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, et al. (2011) MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 121: 1827-1833.
28. Logan KE, Gavier-Widen D, Hewinson RG, Hogarth PJ, (2008) Development of a Mycobacterium bovis intranasal challenge model in mice. Tuberculosis (Edinb) 88: 437-443.
29. Lee LN, Ronan EO, de Lara C, Franken KLM, Ottenhoff TH, et al. (2011) CXCR6 is a marker for protective antigen-specific cells in the lungs after intra-nasal immunization against M. tuberculosis. Infect Immun 79: 3328-3337.
30. Santosuosso M, Zhang X, McCormick S, Wang J, Hitt M, et al. (2005) Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol 174: 7986-7994.
31. Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, et al. (2009) Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine 27: 4412-4423.
32. Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, et al. (2007) The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 25: 14-18.
33. Lu D, Hickey AJ, (2007) Pulmonary vaccine delivery. Expert Rev Vaccines 6: 213-226.
34. Song K, Bolton DL, Wilson RL, Camp JV, Bao S, et al. (2010) Genetic immunization in the lung induces potent local and systemic immune responses. Proc Natl Acad Sci U S A 107: 22213-22218.
35. Rosenthal SR, McEnery JT, Raisys N, (1968) Aerogenic BCG vaccination against tuberculosis in animal and human subjects. J Asthma Res 5: 309-323.